The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

ArQule Ltd. / See Company Profile

Alliance / Inpharmatica gets rights to ArQule's ADMET IP / Strategic Transactions / Deal Date: Jun. 1, 2003 / Publish Date: Jul. 1, 2003

Visterra Inc. / See Company Profile

Acquisition / Otsuka buys Visterra for $430mm in cash / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 12, 2018

Alliance / Visterra, Vir team up in infectious disease deal that could exceed $1bn / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Financing / Visterra closes $46.7mm Series C round / Strategic Transactions / Deal Date: Jun. 1, 2016 / Update Date: Oct. 1, 2017

Axovant Sciences Ltd. / See Company Profile

Alliance / Axovant licenses worldwide rights to Benitec's BB301 and five other CNS gene therapy programs / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 12, 2018

Alliance / Axovant gains worldwide license to Oxford BioMedica's OXB102 gene therapy candidate for PD / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 8, 2018

Financing / Axovant raises $25mm in PIPE to support licensing of OXB102 from Oxford BioMedica / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 7, 2018


Medical Devices

Email Alert | RSS Feed

TVA Medical Inc. / See Company Profile

Financing / TVA Medical enters $7mm debt agreement with Square 1 Bank / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Jul. 10, 2018

Acquisition / Becton Dickinson acquires TVA Medical / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Financing / TVA Medical brings in $15mm through Series C round / Strategic Transactions / Deal Date: Oct. 1, 2015 / Publish Date: Oct. 8, 2015

EndoGastric Solutions Inc. / See Company Profile

Financing / EndoGastric Solutions raises $30.5mm in late-stage round / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Financing / EndoGastric Solutions secures up to $50mm in late-stage round / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 16, 2015

Financing / Series G leads to $30mm for EndoGastric Solutions / Strategic Transactions / Deal Date: May 1, 2014 / Publish Date: May 7, 2014

Molnlycke Health Care AB / See Company Profile

Acquisition / Molnlycke acquires SastoMed / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 6, 2018

Alliance / Covalon grants Molnlycke exclusive rights to silicone adhesive technology and dressings / Strategic Transactions / Deal Date: Nov. 1, 2013 / Publish Date: Nov. 7, 2013

Acquisition / Brennen Medical divests its wound and burn care business to Molnlycke / Strategic Transactions / Deal Date: Feb. 1, 2012 / Publish Date: Mar. 9, 2012


In Vitro Diagnostics

Email Alert | RSS Feed

Saladax Biomedical Inc. / See Company Profile

Alliance / Janssen Pharmaceutica grants Saladax exclusive rights to diagnostics-related patents / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jul. 2, 2018

Financing / Saladax begins Series D round with $22.4mm investment from Fosun / Strategic Transactions / Deal Date: Mar. 1, 2013 / Publish Date: Mar. 21, 2013

Alliance / Fosun Pharma will sell Saladax's MyCare cancer assays in China / Strategic Transactions / Deal Date: Mar. 1, 2013 / Publish Date: Mar. 21, 2013

Biodesix Inc. / See Company Profile

Acquisition / Biodesix acquires Integrated Diagnostics / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Alliance / Bioyong to sell version of Biodesix' VeriStrat cancer test in China / Strategic Transactions / Deal Date: Jan. 1, 2017 / Publish Date: Jan. 14, 2017

Financing / Biodesix raises $22mm through Series F round; $7mm added / Strategic Transactions / Deal Date: Feb. 1, 2016 / Update Date: Jul. 1, 2016

Lab21 Ltd. / See Company Profile

Acquisition / Lab21 acquires Omega Diagnostics' infectious disease biz for up to £2.18mm / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jul. 12, 2018

Acquisition / Trinity Biotech gets syphilis and malaria assets from Lab21 / Strategic Transactions / Deal Date: Oct. 1, 2013 / Publish Date: Oct. 30, 2013

Acquisition / Lab21 pays undisclosed amount for Myconostica / Strategic Transactions / Deal Date: May 1, 2011 / Publish Date: Jun. 3, 2011


Pharmaceuticals

Email Alert | RSS Feed

Lupin Ltd. / See Company Profile

Alliance / Mylan to sell Lupin's etanercept biosimilar / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Acquisition / Lupin expands women's health portfolio through $150mm buy of Symbiomix / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 12, 2017

Alliance / Kyowa gets Japanese rights to ER quetiapine fumarate from Astellas / Strategic Transactions / Deal Date: Feb. 1, 2017 / Publish Date: Mar. 11, 2017

Athenex Inc. / See Company Profile

Alliance / Athenex licenses pegylated arginase from Polytom / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 9, 2018

Alliance / Athenex and Avalon HepaPOC pen deal for liver function tests / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 9, 2018

Financing / Perceptive Advisors invests $100mm in Athenex through stock and debt agreement / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 6, 2018

Tricida Inc. / See Company Profile

Financing / Tricida's initial public offering nets $206.7mm / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jul. 2, 2018

Financing / Tricida enters $100mm loan agreement with Hercules; gets $25mm up front / Strategic Transactions / Deal Date: Mar. 1, 2018 / Update Date: Jun. 1, 2018

Financing / Tricida completes $57.5mm Series D round / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 10, 2017

Biotechnology

Biotechnology

Email Alert | RSS Feed

ArQule Ltd. / See Company Profile

Alliance / Inpharmatica gets rights to ArQule's ADMET IP / Strategic Transactions / Deal Date: Jun. 1, 2003 / Publish Date: Jul. 1, 2003

Visterra Inc. / See Company Profile

Acquisition / Otsuka buys Visterra for $430mm in cash / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 12, 2018

Alliance / Visterra, Vir team up in infectious disease deal that could exceed $1bn / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Financing / Visterra closes $46.7mm Series C round / Strategic Transactions / Deal Date: Jun. 1, 2016 / Update Date: Oct. 1, 2017

Axovant Sciences Ltd. / See Company Profile

Alliance / Axovant licenses worldwide rights to Benitec's BB301 and five other CNS gene therapy programs / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 12, 2018

Alliance / Axovant gains worldwide license to Oxford BioMedica's OXB102 gene therapy candidate for PD / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 8, 2018

Financing / Axovant raises $25mm in PIPE to support licensing of OXB102 from Oxford BioMedica / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 7, 2018

Medical
Devices

Medical Devices

Email Alert | RSS Feed

TVA Medical Inc. / See Company Profile

Financing / TVA Medical enters $7mm debt agreement with Square 1 Bank / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Jul. 10, 2018

Acquisition / Becton Dickinson acquires TVA Medical / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Financing / TVA Medical brings in $15mm through Series C round / Strategic Transactions / Deal Date: Oct. 1, 2015 / Publish Date: Oct. 8, 2015

EndoGastric Solutions Inc. / See Company Profile

Financing / EndoGastric Solutions raises $30.5mm in late-stage round / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Financing / EndoGastric Solutions secures up to $50mm in late-stage round / Strategic Transactions / Deal Date: Dec. 1, 2015 / Publish Date: Dec. 16, 2015

Financing / Series G leads to $30mm for EndoGastric Solutions / Strategic Transactions / Deal Date: May 1, 2014 / Publish Date: May 7, 2014

Molnlycke Health Care AB / See Company Profile

Acquisition / Molnlycke acquires SastoMed / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 6, 2018

Alliance / Covalon grants Molnlycke exclusive rights to silicone adhesive technology and dressings / Strategic Transactions / Deal Date: Nov. 1, 2013 / Publish Date: Nov. 7, 2013

Acquisition / Brennen Medical divests its wound and burn care business to Molnlycke / Strategic Transactions / Deal Date: Feb. 1, 2012 / Publish Date: Mar. 9, 2012

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Saladax Biomedical Inc. / See Company Profile

Alliance / Janssen Pharmaceutica grants Saladax exclusive rights to diagnostics-related patents / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jul. 2, 2018

Financing / Saladax begins Series D round with $22.4mm investment from Fosun / Strategic Transactions / Deal Date: Mar. 1, 2013 / Publish Date: Mar. 21, 2013

Alliance / Fosun Pharma will sell Saladax's MyCare cancer assays in China / Strategic Transactions / Deal Date: Mar. 1, 2013 / Publish Date: Mar. 21, 2013

Biodesix Inc. / See Company Profile

Acquisition / Biodesix acquires Integrated Diagnostics / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Alliance / Bioyong to sell version of Biodesix' VeriStrat cancer test in China / Strategic Transactions / Deal Date: Jan. 1, 2017 / Publish Date: Jan. 14, 2017

Financing / Biodesix raises $22mm through Series F round; $7mm added / Strategic Transactions / Deal Date: Feb. 1, 2016 / Update Date: Jul. 1, 2016

Lab21 Ltd. / See Company Profile

Acquisition / Lab21 acquires Omega Diagnostics' infectious disease biz for up to £2.18mm / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jul. 12, 2018

Acquisition / Trinity Biotech gets syphilis and malaria assets from Lab21 / Strategic Transactions / Deal Date: Oct. 1, 2013 / Publish Date: Oct. 30, 2013

Acquisition / Lab21 pays undisclosed amount for Myconostica / Strategic Transactions / Deal Date: May 1, 2011 / Publish Date: Jun. 3, 2011

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Lupin Ltd. / See Company Profile

Alliance / Mylan to sell Lupin's etanercept biosimilar / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 10, 2018

Acquisition / Lupin expands women's health portfolio through $150mm buy of Symbiomix / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 12, 2017

Alliance / Kyowa gets Japanese rights to ER quetiapine fumarate from Astellas / Strategic Transactions / Deal Date: Feb. 1, 2017 / Publish Date: Mar. 11, 2017

Athenex Inc. / See Company Profile

Alliance / Athenex licenses pegylated arginase from Polytom / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 9, 2018

Alliance / Athenex and Avalon HepaPOC pen deal for liver function tests / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 9, 2018

Financing / Perceptive Advisors invests $100mm in Athenex through stock and debt agreement / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 6, 2018

Tricida Inc. / See Company Profile

Financing / Tricida's initial public offering nets $206.7mm / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jul. 2, 2018

Financing / Tricida enters $100mm loan agreement with Hercules; gets $25mm up front / Strategic Transactions / Deal Date: Mar. 1, 2018 / Update Date: Jun. 1, 2018

Financing / Tricida completes $57.5mm Series D round / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 10, 2017

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel